{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:10:55Z","timestamp":1791360655018,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OVV 152411"],"award-info":[{"award-number":["OVV 152411"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["MethodsX"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.mex.2020.100806","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T20:03:38Z","timestamp":1582142618000},"page":"100806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Titration methods for rVSV-based vaccine manufacturing"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-5781","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"G\u00e9linas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Kiesslich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9nald","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-8815","authenticated-orcid":false,"given":"Amine A.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mex.2020.100806_bib0001","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.mex.2020.100806_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/02648725.2018.1474320","article-title":"Rhabdoviruses as vaccine platforms for infectious disease and cancer","volume":"34","author":"Zemp","year":"2018","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.mex.2020.100806_bib0003","article-title":"First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response","year":"2019","journal-title":"Press Announc"},{"key":"10.1016\/j.mex.2020.100806_bib0004","first-page":"367","article-title":"Ebola is now \u201cpreventable and treatable,\u201d says WHO after approving vaccine in record time","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.mex.2020.100806_bib0005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.mex.2020.100806_bib0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/jvi.55.2.366-373.1985","article-title":"Defective Interfering Virus Particles Modulate Virulence","volume":"55","author":"Cave","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.mex.2020.100806_bib0007","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly Effective Control of an AIDS Virus Challenge in Macaques by Using Vesicular Stomatitis Virus and Modified Vaccinia Virus Ankara Vaccine Vectors in a Single-Boost Protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.mex.2020.100806_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100009","article-title":"rVSV\u0394G-ZEBOV-GP (also designated V920) Recombinant Vesicular Stomatitis Virus Pseudotyped with Ebola Zaire Glycoprotein: Standardized Template with Key Considerations for a Risk\/Benefit Assessment","volume":"1","author":"Monath","year":"2019","journal-title":"Vaccine X"},{"key":"10.1016\/j.mex.2020.100806_bib0009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jviromet.2018.06.015","article-title":"Development of a droplet digital RT-PCR for the quantification of foot-and-mouth virus RNA","volume":"259","author":"Pinheiro-de-Oliveira","year":"2018","journal-title":"J. Virol. Methods."},{"key":"10.1016\/j.mex.2020.100806_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijfoodmicro.2015.02.006","article-title":"A comparative study of digital RT-PCR and RT-qPCR for quantification of Hepatitis A virus and Norovirus in lettuce and water samples","volume":"201","author":"Coudray-Meunier","year":"2015","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.mex.2020.100806_bib0011","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mex.2020.100806_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02217-x","article-title":"Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: From variable nonsense to publication quality data","volume":"7","author":"Taylor","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mex.2020.100806_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/hgtb.2019.031","article-title":"Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors","volume":"30","author":"Furuta-Hanawa","year":"2019","journal-title":"Hum. Gene Ther. Methods."},{"key":"10.1016\/j.mex.2020.100806_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/hgtb.2013.131","article-title":"Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR","volume":"25","author":"Lock","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.mex.2020.100806_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mex.2020.100806_bib0016","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1016\/j.vaccine.2019.09.044","article-title":"Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells","volume":"37","author":"G\u00e9linas","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.mex.2020.100806_bib0017","series-title":"Vaccine Des.","first-page":"245","article-title":"Designing efficacious vesicular stomatitis virus-vectored vaccines against Ebola virus","author":"Wong","year":"2016"},{"key":"10.1016\/j.mex.2020.100806_bib0018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jbiotec.2018.11.023","article-title":"Optimization of Production of Vesicular Stomatitis Virus (VSV) in suspension serum-free culture medium at high cell density","volume":"289","author":"Elahi","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.mex.2020.100806_bib0019","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/hgtb.2017.086","article-title":"Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines","volume":"28","author":"Manceur","year":"2017","journal-title":"Hum. Gene Ther. Methods."},{"key":"10.1016\/j.mex.2020.100806_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mex.2020.100806_bib0021","article-title":"The method of \u201cright and wrong cases\u201d('constant stimuli\u2019) without Gauss's formulae","volume":"1904-1920","author":"Spearman","year":"1908","journal-title":"Br. J. Psychol."},{"key":"10.1016\/j.mex.2020.100806_bib0022","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn. Schmiedebergs. Arch. Exp. Pathol. Pharmakol."},{"key":"10.1016\/j.mex.2020.100806_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012465330-6\/50003-8","article-title":"Virus Isolation and Quantitation","author":"Hierholzer","year":"1996","journal-title":"Virol. Methods Man."},{"key":"10.1016\/j.mex.2020.100806_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/mp.54.2.86","article-title":"Recovery efficiencies of nucleic acid extraction kits as measured by quantitative LightCycler\u2122 PCR","volume":"54","author":"Read","year":"2001","journal-title":"J. Clin. Pathol. - Mol. Pathol."},{"key":"10.1016\/j.mex.2020.100806_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods."},{"key":"10.1016\/j.mex.2020.100806_bib0026","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jviromet.2013.05.015","article-title":"Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity","volume":"193","author":"Smither","year":"2013","journal-title":"J. Virol. Methods."},{"key":"10.1016\/j.mex.2020.100806_bib0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12981-017-0179-2","article-title":"Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses","volume":"14","author":"Racine","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.mex.2020.100806_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell."},{"key":"10.1016\/j.mex.2020.100806_bib0029","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1016\/j.vaccine.2018.09.002","article-title":"Rapid quantification of vesicular stomatitis virus in Vero cells using Laser Force Cytology","volume":"36","author":"Hebert","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.mex.2020.100806_bib0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/jvi.51.2.515-521.1984","article-title":"Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs.","volume":"51","author":"Meier","year":"1984","journal-title":"J. Virol."},{"key":"10.1016\/j.mex.2020.100806_bib0031","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/biot.201400429","article-title":"Defective interfering viruses and their impact on vaccines and viral vectors","volume":"10","author":"Frensing","year":"2015","journal-title":"Biotechnol. J."}],"container-title":["MethodsX"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016120300261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016120300261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:39:22Z","timestamp":1791301162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215016120300261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":31,"alternative-id":["S2215016120300261"],"URL":"https:\/\/doi.org\/10.1016\/j.mex.2020.100806","relation":{},"ISSN":["2215-0161"],"issn-type":[{"value":"2215-0161","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Titration methods for rVSV-based vaccine manufacturing","name":"articletitle","label":"Article Title"},{"value":"MethodsX","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mex.2020.100806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.044","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100806"}}